784 related articles for article (PubMed ID: 19733826)
1. Identifying factors that affect patients' willingness to pay for inhaled insulin.
Pinto SL; Holiday-Goodman M; Black CD; Lesch D
Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes.
Guimarães C; Marra CA; Colley L; Gill S; Simpson S; Meneilly G; Queiroz RH; Lynd LD
Diabetes Technol Ther; 2009 Sep; 11(9):567-73. PubMed ID: 19764835
[TBL] [Abstract][Full Text] [Related]
3. A valuation of patients' willingness-to-pay for insulin delivery in diabetes.
Guimarães C; Marra CA; Colley L; Gill S; Simpson SH; Meneilly GS; Queiroz RH; Lynd LD
Int J Technol Assess Health Care; 2009 Jul; 25(3):359-66. PubMed ID: 19619355
[TBL] [Abstract][Full Text] [Related]
4. Inhaled insulin--does it become reality?
Siekmeier R; Scheuch G
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
[TBL] [Abstract][Full Text] [Related]
5. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
[TBL] [Abstract][Full Text] [Related]
6. Willingness-to-pay for community-based insurance in Burkina Faso.
Dong H; Kouyate B; Cairns J; Mugisha F; Sauerborn R
Health Econ; 2003 Oct; 12(10):849-62. PubMed ID: 14508869
[TBL] [Abstract][Full Text] [Related]
7. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
8. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
[TBL] [Abstract][Full Text] [Related]
9. Patients' willingness to pay for pharmacist-provided menopause and hormone replacement therapy consultations.
Barner JC; Branvold A
Res Social Adm Pharm; 2005 Mar; 1(1):77-100. PubMed ID: 17138467
[TBL] [Abstract][Full Text] [Related]
10. Willingness to pay for inhaled insulin: a contingent valuation approach.
Sadri H; MacKeigan LD; Leiter LA; Einarson TR
Pharmacoeconomics; 2005; 23(12):1215-27. PubMed ID: 16336016
[TBL] [Abstract][Full Text] [Related]
11. Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis.
Cham PM; Chen SC; Grill JP; Jonk YC; Warshaw EM
Br J Dermatol; 2007 May; 156(5):922-8. PubMed ID: 17459013
[TBL] [Abstract][Full Text] [Related]
12. Patient preferences for depression treatment programs and willingness to pay for treatment.
Morey E; Thacher JA; Craighead WE
J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
[TBL] [Abstract][Full Text] [Related]
13. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
von Ferber L; Köster I; Hauner H
Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
[TBL] [Abstract][Full Text] [Related]
14. Willingness to pay for health insurance among rural and poor persons: field evidence from seven micro health insurance units in India.
Dror DM; Radermacher R; Koren R
Health Policy; 2007 Jun; 82(1):12-27. PubMed ID: 16971017
[TBL] [Abstract][Full Text] [Related]
15. Survey of parental willingness to pay and willingness to stay for "painless" intravenous catheter placement.
Walsh BM; Bartfield JM
Pediatr Emerg Care; 2006 Nov; 22(11):699-703. PubMed ID: 17110860
[TBL] [Abstract][Full Text] [Related]
16. Willingness to pay for community-based health insurance in Nigeria: do economic status and place of residence matter?
Onwujekwe O; Okereke E; Onoka C; Uzochukwu B; Kirigia J; Petu A
Health Policy Plan; 2010 Mar; 25(2):155-61. PubMed ID: 20156920
[TBL] [Abstract][Full Text] [Related]
17. Equity shortfalls & failure of the welfare state: community willingness to pay for health care at government facilities in Jehlum (Pakistan).
Masud TI; Farooq N; Ghaffar A
J Ayub Med Coll Abbottabad; 2003; 15(4):43-9. PubMed ID: 15067833
[TBL] [Abstract][Full Text] [Related]
18. Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study.
Schöffski O; Breitscheidel L; Benter U; Dippel FW; Müller M; Volk M; Pfohl M
J Med Econ; 2008; 11(4):695-712. PubMed ID: 19450076
[TBL] [Abstract][Full Text] [Related]
19. Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe.
Baser O; Bouchard J; DeLuzio T; Henk H; Aagren M
Adv Ther; 2010 Feb; 27(2):94-104. PubMed ID: 20352392
[TBL] [Abstract][Full Text] [Related]
20. Patient valuation of pharmacist services for self care with OTC medications.
Hong SH; Spadaro D; West D; Tak SH
J Clin Pharm Ther; 2005 Jun; 30(3):193-9. PubMed ID: 15896235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
